Millipore Sigma Vibrant Logo

05-23-0657 [Sar⁹, Met(O₂)¹¹]-Substance P

[Sar⁹, Met(O₂)¹¹]-Substance P : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: RPKPQQFFSarLM(O₂)

05-23-0657
  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
—
Demander le prix
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      CAS #Empirical Formula
      110880-55-2C₆₄H₁₀₀N₁₈O₁₅S
      Description
      OverviewSelective NK-1 receptor agonist. Stimulates the formation of inositol phosphate (EC50 = 3.8 nM) and enhances taurine release (EC50 = 7.4 nM) from human astrocytoma cell line.
      Catalogue Number05-23-0657
      Brand Family Calbiochem®
      SynonymsRPKPQQFFSarLM(O₂)
      References
      ReferencesOury-Donat, F., et al. 1994. J. Neurochem. 62, 1399. Rouissi, N., et al. 1993. Life Sci. 52, L103. Giuliani, S., et al. 1988. Eur. J. Pharmacol. 150, 377.
      Product Information
      CAS number110880-55-2
      FormLyophilized
      Hill FormulaC₆₄H₁₀₀N₁₈O₁₅S
      Chemical formulaC₆₄H₁₀₀N₁₈O₁₅S
      Hygroscopic Hygroscopic
      Sold on the basis of peptide contentY
      Applications
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Peptide ContentY
      Peptide SequenceH-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met(O₂)-NH₂
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 to months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      05-23-0657 0

      Documentation

      [Sar⁹, Met(O₂)¹¹]-Substance P Certificats d'analyse

      TitreNuméro de lot
      05-23-0657

      Références bibliographiques

      Aperçu de la référence bibliographique
      Oury-Donat, F., et al. 1994. J. Neurochem. 62, 1399. Rouissi, N., et al. 1993. Life Sci. 52, L103. Giuliani, S., et al. 1988. Eur. J. Pharmacol. 150, 377.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision18-September-2008 RFH
      SynonymsRPKPQQFFSarLM(O₂)
      DescriptionSelective NK-1 receptor agonist. Stimulates the formation of inositol phosphate (EC50 = 3.8 nM) and enhances taurine release (EC50 = 7.4 nM) from human astrocytoma cell line.
      FormLyophilized
      CAS number110880-55-2
      Chemical formulaC₆₄H₁₀₀N₁₈O₁₅S
      Peptide SequenceH-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met(O₂)-NH₂
      Purity≥98% by HPLC
      Solubility5% Acetic acid (1 mg/ml)
      Storage -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 to months at -20°C.
      Toxicity Standard Handling
      ReferencesOury-Donat, F., et al. 1994. J. Neurochem. 62, 1399. Rouissi, N., et al. 1993. Life Sci. 52, L103. Giuliani, S., et al. 1988. Eur. J. Pharmacol. 150, 377.